Aurotioprol
Chemical compound
- M01CB05 (WHO)
- Sodium aurothiopropanolsulfonate
- 27279-43-2 Y
- 44144564
- 8628381
- G7097J63E9
- DTXSID60912312
- Interactive image
- C(C(CS(=O)(=O)[O-])O)[S-].[Na+].[Au+]
InChI
- InChI=1S/C3H8O4S2.Au.Na/c4-3(1-8)2-9(5,6)7;;/h3-4,8H,1-2H2,(H,5,6,7);;/q;2*+1/p-2
- Key:KBWWFTIQBJUOQR-UHFFFAOYSA-L
Aurotioprol is a gold salt used as an antirheumatic agent.[1][2]
References
- ^ Perrier P, Raffoux C, Thomas P, Tamisier JN, Busson M, Gaucher A, Streiff F (September 1985). "HLA antigens and toxic reactions to sodium aurothiopropanol sulphonate and D-penicillamine in patients with rheumatoid arthritis". Annals of the Rheumatic Diseases. 44 (9): 621–4. doi:10.1136/ard.44.9.621. PMC 1001721. PMID 3876081.
- ^ Veys EM, Mielants H, Verbruggen G (1987). "Goldsalts, levamisole and D-penicillamine as first choice slow-acting antirheumatic drugs in rheumatoid arthritis--a long-term follow-up study". Clinical and Experimental Rheumatology. 5 (2): 111–6. PMID 3608266.
- v
- t
- e
Specific antirheumatic products / DMARDs (M01C)
- Oxycinchophen
- Sodium aurothiomalate
- Sodium aurothiosulfate
- Auranofin
- Aurothioglucose
- Aurotioprol
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e